Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

The only gene-editing therapy currently on the market is a CRISPR–Cas9-based treatment for two blood disorders, sickle-cell ...

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

The slice of code — a stretch of DNA that acts like a dial to turn up the expression of certain genes — expanded the outer ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

The genome structure—how genes are organized within DNA sequences in an organism—is fundamental to the processes and ...

Trust of our neighbors is increasingly required to our shared human experience.